Evidence map›Paper›PMID 31312746›Full record

ArticleContemporary clinical trials communications2019

Patient preferences for using mobile technologies in clinical trials.

Brian Perry, Cindy Geoghegan, Li Lin, F Hunter McGuire, Virginia Nido, Brigid Grabert, Steve L Morin, Zachary P Hallinan, Amy Corneli

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Remote digital smart device follow-up in prospective clinical trials: early insights from ORBITA-2, ORBITA-COSMIC, and ORBITA-STAR.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  17. Development and Evaluation of the Clinical Trial HEalth Knowledge and Beliefs Scale (CHEKS).International journal of environmental research and public health · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brian PerryClinical Trials Transformation Initiative, Durham, NC, USA.
Cindy GeogheganPatient and Partners LLC, Madison, CT, USA.
Li LinDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
F Hunter McGuireClinical Trials Transformation Initiative, Durham, NC, USA.
Virginia NidoGenentech, Inc, South San Francisco, CA, USA.
Brigid GrabertDepartment of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Steve L MorinOffice of Health and Constituent Affairs, US Food and Drug Administration, Silver Spring, MD, USA.
Zachary P HallinanClinical Trials Transformation Initiative, Durham, NC, USA.
Amy CorneliClinical Trials Transformation Initiative, Durham, NC, USA.
Duke University · USUniversity of North Carolina at Chapel Hill · USUnited States Food and Drug Administration · US

Funding

FDA HHS R18 FD005292FDA HHS U18 FD005292
6 · The paper itself

Abstract

The use of mobile technologies to collect participant data in clinical trials offers a number of scientific and logistical advantages. However, little is known about potential research participant preferences about how to incorporate mobile technologies into the design and conduct of a trial. Using a web-based survey which described hypothetical mobile clinical trial and traditional clinical trial scenarios, we explored patients' perceptions of and willingness to participate in mobile and traditional clinical trials, their preferred trial procedures related to the use of mobile technologies, and the preferred attributes of mobile technologies. The majority of survey respondents reported that they would prefer participating in a clinical trial that used mobile technology than a traditional trial that relied on standard in-clinic assessments. They expressed that mobile clinical trials offered greater convenience, a reduction of in-person clinic visits, and greater data collection accuracy. Respondents also reported preferences for the frequency of in-clinic visits during mobile clinical trials, device training and troubleshooting, data privacy and confidentiality, the location of data storage, and user access to data collected by the trial device. As research participants become more involved in capturing their own data to inform trial endpoints, their user-preferences of mobile technology, such as those described here, should be considered in the design and conduct of mobile clinical trials.

Indexed as

Mobile clinical trialsMobile technologyPatient-centeredPatient preferencesWearable

Identifiers

PMID31312746
PMCPMC6610628
OpenAlexW2949654782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.